Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

Backgrounds. The aim of this study was to appraise the relationship between serum fragmented cytokeratin-18(CK-18), controlled attenuation parameter (CAP), and liver steatosis assessed by ultrasound (US) in nonalcoholic fatty liver disease (NAFLD) patients. Methods. Patients who underwent abdominal...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	International Journal of Hepatology
Online Access:	http://dx.doi.org/10.1155/2018/9252536
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver
by: M. Del Ben, et al.
Published: (2014-01-01)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
by: Anna Virginia Adriana Pirozzi, et al.
Published: (2020-01-01)

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
by: Parthana Rani Sutradhar, et al.
Published: (2024-01-01)

Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD)
by: Vanja Kalacun, et al.
Published: (2025-12-01)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
by: Concepcion Gonzalez, et al.
Published: (2013-01-01)

Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
by: Wenying Qiao, et al.
Published: (2025-01-01)

Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
by: Ali Mahmoudi, et al.
Published: (2022-01-01)

Upper Gastrointestinal Bleed due to Duodenal Metastases of Lung Adenocarcinoma: Report of Two Cases and Review of Literature
by: Sumitro Kosasih, et al.
Published: (2019-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01)

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes
by: Krikor Kichian, et al.
Published: (2003-01-01)

Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children
by: Marta Flisiak-Jackiewicz, et al.
Published: (2018-01-01)

Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD)
by: Yusri Diane Jurnalis, et al.
Published: (2014-01-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice
by: Haiping Wang, et al.
Published: (2015-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
by: Roberto Martínez-Beamonte, et al.
Published: (2020-01-01)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01)

TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis
by: Xiang Hu, et al.
Published: (2020-01-01)

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01)

Outcomes Following Liver Transplantation for Patients with Alcohol- Versus Nonalcohol-Induced Liver Disease
by: Dory Abosh, et al.
Published: (2000-01-01)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01)

Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice
by: Luciana Lontro Alves, et al.
Published: (2024-01-01)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
by: Giuseppina Palladini, et al.
Published: (2019-01-01)

The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet
by: Farzad Shidfar, et al.
Published: (2018-01-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
by: Camelia Cojocariu, et al.
Published: (2020-01-01)

Nonalcoholic Fatty Liver Disease: A Clinical Approach and Review
by: Maitreyi Raman, et al.
Published: (2006-01-01)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
by: Anna Alisi, et al.
Published: (2011-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats
by: Suja Rani Sasidharan, et al.
Published: (2014-01-01)

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
by: Changzhou Cai, et al.
Published: (2021-01-01)

The Increased Activity of Liver Lysosomal Lipase in Nonalcoholic Fatty Liver Disease Contributes to the Development of Hepatic Insulin Resistance
by: Monika Cahova, et al.
Published: (2012-01-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
by: Şule Demir, et al.
Published: (2016-01-01)

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
by: Yasuka Matsunaga, et al.
Published: (2015-01-01)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
by: Caihua Wang, et al.
Published: (2019-01-01)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
by: Rajalingham Sakthiswary, et al.
Published: (2014-01-01)